Skip to main content

Antisense Oligodeoxynucleotide Technology

Application to CNS Neuropharmacology

  • Protocol
In Vivo Neuromethods

Part of the book series: Neuromethods ((NM,volume 32))

  • 385 Accesses

Abstract

With the advent of molecular cloning techniques in the past decade, a large number of novel gene products with unknown functions have been identified in the brain. For instance, an explosive growth has occurred in the discovery of many new receptor subtypes or receptors for most neurotransmitters. However, the lack of truly selective ligands for each of these new receptors makes it impossible to investigate their functional roles. Establishing the precise function of the newly identified receptors is an essential step for the understanding of their cellular mechanisms which may be pivotal in important neurophysiological processes and may lead to understanding of neurological or psychiatric diseases and/or their treatement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akabayashi, A., Wahlestedt, C, Alexander, J T, and Leibowitz, S F. (1994) Specific inhibition of neuropeptide Y synthesis in arcuate neucleus by antisense ohgonucleotides suppresses feeding behavior and insuhn secretion Mol Brain Res 21, 55–61

    Article  PubMed  CAS  Google Scholar 

  • Apostolakis, E. M, Garai, J, Fox, C, Smith, C L, Watson, S J, Clark, J H, and O’Malley, W (1996) Dopaminergic regulation of progesterone receptors bram D5 dopamine receptors mediate induction of lordosis by Dl-like agonists in rats. J Neurosci 16, 4823–4834

    PubMed  CAS  Google Scholar 

  • Bencsics, C, Wachtel, S R, Milstein, S, Hatakeyama, K, Becker, J B, and Kang, U J (1996) Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts J Neurosci. 16, 4449–4456

    PubMed  CAS  Google Scholar 

  • Bergan, R, Connell, Y, Fahmy, B, Kyle, E, and Neckers, L (1994) Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined seuqnce and backbone structure Nucleic Acids Res 22, 2150–2154

    Article  PubMed  CAS  Google Scholar 

  • Berhow, M T, Hiroe, N, and Nestler, E J (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine J Neurosci 16, 4707–4715.

    PubMed  CAS  Google Scholar 

  • Brysh, W, Rifai, A, Tischmeyer, W., and Schlingensiepen, K-H (1996) Antisense-mediated inhibition of protein synthesis rational drug design, pharmacokinetics, intracerebral application, and organ uptake of phosphorothioate oligodeoxynucleotides, in Methods tn Molecular Medicine Antisense Therapeutics, (Agrawal, S, ed ), Humana, Totowa, NJ, pp 159–182

    Google Scholar 

  • Casticas, M Osen-Sand, A, Staple, J K, Jones, K A, Ayala, G, Knowles, J. Grennmgloh, C, Pich, E M., and Casticas, S (1996) Antisense blockade of expression SNAP-25 m vitro and in vivo, in Methods in Molecular Medicine Antisense Therapeutics, (Agrawal, S., ed.), Humana Press, Totowa, NJ, pp 57–86

    Google Scholar 

  • Chavany, C, Connell, Y, and Neckers, L (1995) Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Mol Pharmacology 48, 738–746

    CAS  Google Scholar 

  • Chiasson, B. J, Amstrong, J N, Hooper, M. L., Murphy, P. R, and Robertson, H A (1994) The application of antisense oligonucleotides technology to the brain, some pitfalls Cell Mol Neurobiol 14, 507–521.

    Article  PubMed  CAS  Google Scholar 

  • Chiasson, J. B, Hong, M, Hooper, M L, Amstrong, J N, Murphy P. R, and Robertson, H. A (1996) Antisense therapeutics in the central nervous system The inducion of c-fos, in Methods in Molecular Medicine Antisense Therapeutics, (Agrawal, S, ed ), Humana, Totowa, NJ, pp 225–245

    Google Scholar 

  • Cohen, J S (1991) Oligonucleotides as therapeutic agents Pharmac Ther 52, 211–225

    Article  CAS  Google Scholar 

  • Gao, W-Y., Han, F.-S, Storm, C, Egan, W, and Cheng, Y-C 1992. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology Mol Pharmacology 41, 223–229

    Google Scholar 

  • Georgieva, J, Heihg, M, Nylander, I, Herrera-Marschitz, M, and Trerenius, L (1995) In vivo antisense inhibition of prodynorphin expression in rat striatum. dose-dependence and sequence specificity. Neurosci. Lett 92, 69–71

    Article  Google Scholar 

  • Gerlai, R. (1996) Gene-targeting studies of mammalian behavior, is it the muta tion or the background genotype? Trends Neurosci 19, 177–181

    Article  PubMed  CAS  Google Scholar 

  • Heilig, M, Engel, J A, and Soderpalm B (1993) C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine Eur J Pharmacol 236, 339–340

    Article  PubMed  CAS  Google Scholar 

  • Heilig, M (1994) Antisense technology prospects for treatment of neuropsychiatnc disorders. CNS Drugs 1, 405–409

    Article  Google Scholar 

  • Hélène, C and Toulme, J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids Biochemica Biophysica Acta 1049, 99–125.

    Google Scholar 

  • Hunter, A J, Leslie, R. A., Gloger, I. S., and Lawrence, M. (1995) Probing the function of novel genes in the nervous system’ is antisense the answer? Trends Neurosci 18, 329–331.

    Article  PubMed  CAS  Google Scholar 

  • Karle, J and Nielsen, M (1995) Modest reduction of benzodiazepine binding in rat brain in vivo induced by antisense oligonucleotide to GABAA receptor γ2Subunit subtype. Eur J Pharmacol 291, 439–441.

    Article  PubMed  CAS  Google Scholar 

  • Korte, S. M., De Kloet, E R, Buwalda, B., Bouman, S D., and Bohus, B. (1996) Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Euro J Pharmacol 301, 19–25

    Article  CAS  Google Scholar 

  • Lai J., Bilsky, E J, Rothman, R B., and Porreca, F (1994) Treatment with antisense oligodeoxynucleotide to opiod 8 receptor selectively inhibits δ2-agonist antinociception NeuroReport 5, 1049–1052

    Article  PubMed  CAS  Google Scholar 

  • Landgraf, R. Gerstberger, R, Montkowski, A., Probst, J. C, Wotjak, C. T, Holsboer, F., and Engelmann, M (1995) VI vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci 15, 4250–4258

    PubMed  CAS  Google Scholar 

  • Lima, W F, Moma, B P, Ecker, D J, and Freier, S M (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics Biochemistry 31, 12, 055–12, 061

    Article  CAS  Google Scholar 

  • Maclntyre, T L, Andrews, M, and Roberts, D C S (1995) Microinjection of dopamine D2 receptor antisense oligonucleotides disrupts cocaine selfadmmistration in the rat. Soc Neurosci Abst 288 2

    Google Scholar 

  • McCarthy, M M, Masters, D B, Rimvall, K, Schwartz-Giblin, S., and Pfaff, D W (1994) Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNA modulate reproductive behavior in the female rat Brain Res 636, 209–220

    Article  PubMed  CAS  Google Scholar 

  • Meeker, R, LeGrand, G, Ramirez, J, Smith, T, and Shih, Y-H (1995) Antisense vasopressin oligonucleotides uptake, turover, distrubution, toxicity and behavioral effects J Neuroendocrinal 7, 419–428

    Article  CAS  Google Scholar 

  • Neckers, L M (1993) Cellular internalization of oligodeoxynucleotides, in Antisense Research and Applications, (Crooke, S T and Lebleu, B, eds ), CRC, Boca Raton, PL, pp 451–456

    Google Scholar 

  • Nissbrandt, H, Ekman, A., Eriksson, E, and Heilig, M (1995) Dopamine D3 receptor antisense influences dopamine synthesis in rat brain NeuroReport 6, 573–576

    Article  PubMed  CAS  Google Scholar 

  • Ogawa, S, Olazábal, U E, Parhar, I S, and Pfaff, D W (1994) Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat J Neurosci 14, 1766–1774

    PubMed  CAS  Google Scholar 

  • Pasternak, G W and Standifer, K M 1995 Mapping of opioid receptor using antisense oligodeoxynucleotides correlating their molecular biology and pharmacology Trends Pharmacol Sci 16, 344–350

    Google Scholar 

  • Paxinos, G and Waston, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed, Academic, London

    Google Scholar 

  • Peyman, A, Ryte, A, Helsberg, M., Kretzschmar, G, Mag, M., and Uhlmann, E (1995) Enhanced cellular uptake of G-rich oligodeoxynucleotides Nucleosides Nucleotides 14, 1077–1081

    Article  CAS  Google Scholar 

  • Plata-Salamán, C R, Wilson, C D, Sonti, G, Borkoski, J P., and ffrench-Mullen, J M. H, (1995) Antisense oligodeoxynucleotides to G-protein a-subunit subclasses identify a transductional requirement for modulation of normal feeding dependent on GσOA subunit Mol Brain Res 33. 72–78

    Article  PubMed  Google Scholar 

  • Pollio, G, Xue, P., Zanisi, M, Nicolin, A, and Mggi, A (1993) Antisense oligonucleotide blocks progesterone-mduced lordosis behavior m ovarieectomized rats Mol Brain Res 19, 135–139

    Article  PubMed  CAS  Google Scholar 

  • Silvia, C. P., King, G R., Lee, T H, Xue, Z-Y, Caron, M G, and Ellinwood, E H (1994) Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine Mol. Pharmacol 46, 51–57

    PubMed  CAS  Google Scholar 

  • Skutella, T, Probst, J C, Jinkowski, G F, Holsboer, F, and Spanagel, R (1994) Ventral tegmental area (VTA) injection of tyrosine hydroxylase phosphorothioate antisense oligonucleotide supress operant behavior in rats. Neurosci Lett 167, 55–58

    Article  PubMed  CAS  Google Scholar 

  • Standaert, D G, Testa, C M, Rudolf, G D, and Hoolingsworth Z R (1996) Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation J Pharmacol Exp Ther 276, 342–352

    PubMed  CAS  Google Scholar 

  • Standifer, K M, Jenab, S, Su, W Chien, C-C. Pan, Y-X, Inturnsi, C. E, and Pasternak, G W (1995) Antisense oligodeoxynucleotides to cloned δ receptor DOR-1’ uptake, stability, and regulation of gene expression J Neurochem 65, 1981–1987

    Article  PubMed  CAS  Google Scholar 

  • Stein, C A and Krieg, A. M (1994) Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides Antisense Res Dev. 4, 67–69

    PubMed  CAS  Google Scholar 

  • Sun, B.-C, Zhang, M, Ouagazzal, A, Tepper, J. M, and Creese, I (1996) Dopamine receptor function an analysis utilising antisense knockout in vivo, in Pharmacological Regulation of Gene Expression in the CNS, (Merchant, K. M, ed.), CRC Press, Boca Raton, FL, pp 51–77

    Google Scholar 

  • Szabó, G, Nunley, K. R, and Hoffman, P L (1996) Antisense oligonucleotide to c-fos blocks the ability of arginine vasopressin to maintain ethanol toler ance Eur J Pharmacol 306, 67–72

    Article  PubMed  Google Scholar 

  • Szklarczyk, A and Kaczmarek, L, (1995) Antisense oligodeoxynucleotides sta bility and distribution after intracerebral injection into rat brain J Neurosci Methods 60, 181–187.

    Article  PubMed  CAS  Google Scholar 

  • Tepper, J. M., Sun, B-C, Martin, L P., and Creese, I (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockoudown in vivo J Neurosci 17, 2519–2530

    PubMed  CAS  Google Scholar 

  • Wada, J, Lm, Z, Alvares, K, Kumar, A, Wallner, E, Makino, H, and Kanwar, Y (1993) Cloning of cDNA for asubunit of mouse insuline-like growth factor I receptor and the role of the receptor in metanephnc development Proc Natl Acad Sci USA 90, 10360–10364

    Article  PubMed  CAS  Google Scholar 

  • Wagner, R W, Matteucci, M D, Grant, D, Huang, T, and Froehler, B C (1996) Potent and selective inhibition of gene expression by antisense heptanucleotide Nature Biotech 14, 840–844

    Article  CAS  Google Scholar 

  • Wahlestedt, C Golanov, E, Yamamoto, S, Yee, F, Ericson, H, Yoo, H., Inturnsi, C. E, and Reis, D J. (1993a) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infractions Nature 363, 260–263

    Article  PubMed  CAS  Google Scholar 

  • Wahlestedt, C, Pich, E M, Koob, G F, Yee, F, and Heihg, M. (1993b) Modulation of anxiety and neuropeptide Y-Yl receptors by antisense oligodeoxynucleotides. Science 259, 528–531

    Article  PubMed  CAS  Google Scholar 

  • Wahlestedt, C (1994) Antisense oligonucleotide strategies in neuropharmacology Trends Pharmacol Sci 15, 42–46

    Article  PubMed  CAS  Google Scholar 

  • Weiss, B, Zhou, L.-W., Zhang, S-P., and Qin, Z-H (1993) Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA Neuroscience 55, 607–612

    Article  PubMed  CAS  Google Scholar 

  • Weiss, B, Zhou, L-W., and Zhang, S.-P. (1996) Dopamine antisense oligodeoxynucleotides as potential novel tools for studying drug abuse, in Antisense Strategies for the Study of Receptor Machanisms, (Raffa, R B and Porreca, F, eds), R. G Landes, Austin, TX, pp 71–91

    Google Scholar 

  • Whitesell, L., Geselowitz, D., Chavany, C, Fahmy, B, Walbridge, S, Alger, J. R, and Neckers, L, M (1993) Stability, clearance, and disposition of mtraventricularly adminstered oligodeoxynucleotides implications for therapeutic application within the central nervous system.Proc Natl Acad Sci USA 90, 4665–4669.

    Article  PubMed  CAS  Google Scholar 

  • Widnell, K L, Self, D. W, Lane, S B., Russell, D. S., Vaidya, V A, Miserendino, M J D, Rubin, C S, Duman, R. S, and Nestler, E. J (1996) Regulation of CREB expression in vivo evidence for functional role in morphine action in the nucleus accumbens J Pharmacol Exp Ther 276, 306–315.

    PubMed  CAS  Google Scholar 

  • Yoon, S K., Lois, C, Alvirez, M, Alvarez-Buylla, A, Falck-Pedersen, E, and Chao, M V. (1996) Adenovirus-mediated gene delivery into neuronal precursors of adult mouse brain Proc Natl Acad Sci USA 93, 11, 974–11, 979

    CAS  Google Scholar 

  • Zhang, M and Creese, I (1993) Antisense oligodeoxynucleotide reduces reduces brain dopamine D2 receptors behavioral correlates Neurosci Lett. 161, 223–226

    Article  PubMed  CAS  Google Scholar 

  • Zhang, M, Ouagazzal, A, Sun, B-C, and Creese, I (1996) Regulation of motor behavior by dopamine receptor subtypes an antisense knockout approach, in The Dopamine Receptors, (Neve, K and Neve, R, eds.), Humana, Totowa, NJ, pp 425–455

    Google Scholar 

  • Zhang, S.-P, Zhou, L-W, Morabito, M, Lm, R C S, and Weiss, B (1996) Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide m mouse brain J Mol Neurosci 7, 13–28

    Article  PubMed  CAS  Google Scholar 

  • Zhao, T-J., Rosenberg, H. C, and Chiu, T H (1996) Treatment with an antisense oligodeoxynucleotide to the GABA A receptor γ2 subunit increases convulsive threshold for β-CCM, a benzodiazepine ‘inverse agonists’, in rats Eur J Pharmacol 306, 61–66.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Humana Press Inc.

About this protocol

Cite this protocol

Ouagazzal, AM., Tepper, J.M., Creese, I. (1998). Antisense Oligodeoxynucleotide Technology. In: In Vivo Neuromethods. Neuromethods, vol 32. Humana Press. https://doi.org/10.1385/0-89603-511-5:295

Download citation

  • DOI: https://doi.org/10.1385/0-89603-511-5:295

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-511-9

  • Online ISBN: 978-1-59259-637-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics